IART | tickerfilter.com

Fundamental analysis

13%

Profitability 17%

Dept financing 25%

Liquidity 39%

Performance 0%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.55%

1 Month

-6.62%

3 Months

26.67%

6 Months

-22.54%

1 Year

-50.14%

2 Year

-60.58%

Key data

Stock price

$22.68

P/E Ratio

66.73

DAY RANGE

$21.92 - $22.66

EPS

$0.30

52 WEEK RANGE

$17.22 - $45.42

52 WEEK CHANGE

-$49.62

MARKET CAP

1.578 B

YIELD

N/A

SHARES OUTSTANDING

77.582 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

10/30/2024

BETA

0.87

PUBLIC FLOAT

AVERAGE 10 VOLUME

$655,997

AVERAGE 30 VOLUME

$551,357

Company detail

CEO: Jan D. de Witte
Region: US
Website: integralife.com
Employees: 3,720
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, surgical headlamps and instrumentation.

IART - INTEGRA LIFESCIENCES HOLDINGS CORP